ResearcherShizuoka Cancer CenterActive in the last 2 years
Kenichi Urakami
Matched on ORCID iD 0000-0002-4751-0978; OpenAlex author ID A5014271968. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 2 papers
Papers 6
- Impact of CYP2A6 Genotype on Survival Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Receiving Perioperative S-1 Therapy. Co-author DOI 10.1097/sla.0000000000007152↗
- Comparison of Familial and Sporadic Pancreatic Cancer: Clinicopathological and Genomic Features. Co-author DOI 10.1245/s10434-025-18556-3↗
- Comprehensive sequencing of circulating tumour DNA in resectable pancreatic cancer. Co-author DOI 10.1093/bjs/znae059↗
- Two Japanese families with familial pancreatic cancer with suspected pathogenic variants of CDKN2A: a case report. Last author DOI 10.1186/s13053-024-00283-7↗
- Characterization of pancreatic cancer with ultra-low tumor mutational burden. Co-author DOI 10.1038/s41598-023-31579-8↗
- Pancreatic adenocarcinoma with a germline PTEN p.Arg234Gln mutation. Co-author DOI 10.1007/s10689-017-0025-7↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ryo Ashida · 5 shared papers, 2023–2026 · strength 1.01
- Paper Comparison of Familial and Sporadic Pancreatic Cancer: Clinicopathological and Genomic Features. DOI 10.1245/s10434-025-18556-3↗
- Paper Impact of CYP2A6 Genotype on Survival Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Receiving Perioperativ… DOI 10.1097/sla.0000000000007152↗
- Paper Comprehensive sequencing of circulating tumour DNA in resectable pancreatic cancer. DOI 10.1093/bjs/znae059↗
- Katsuhiko Uesaka · 5 shared papers, 2018–2026 · strength 0.91
- Paper Comparison of Familial and Sporadic Pancreatic Cancer: Clinicopathological and Genomic Features. DOI 10.1245/s10434-025-18556-3↗
- Paper Impact of CYP2A6 Genotype on Survival Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Receiving Perioperativ… DOI 10.1097/sla.0000000000007152↗
- Paper Comprehensive sequencing of circulating tumour DNA in resectable pancreatic cancer. DOI 10.1093/bjs/znae059↗
- Teiichi Sugiura · 4 shared papers, 2023–2026 · strength 0.83
- Paper Comparison of Familial and Sporadic Pancreatic Cancer: Clinicopathological and Genomic Features. DOI 10.1245/s10434-025-18556-3↗
- Paper Impact of CYP2A6 Genotype on Survival Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Receiving Perioperativ… DOI 10.1097/sla.0000000000007152↗
- Paper Comprehensive sequencing of circulating tumour DNA in resectable pancreatic cancer. DOI 10.1093/bjs/znae059↗
- Keiichi Ohshima · 4 shared papers, 2023–2026 · strength 0.83
- Paper Comparison of Familial and Sporadic Pancreatic Cancer: Clinicopathological and Genomic Features. DOI 10.1245/s10434-025-18556-3↗
- Paper Impact of CYP2A6 Genotype on Survival Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Receiving Perioperativ… DOI 10.1097/sla.0000000000007152↗
- Paper Comprehensive sequencing of circulating tumour DNA in resectable pancreatic cancer. DOI 10.1093/bjs/znae059↗
- Katsuhisa Ohgi · 4 shared papers, 2023–2026 · strength 0.83
- Paper Comparison of Familial and Sporadic Pancreatic Cancer: Clinicopathological and Genomic Features. DOI 10.1245/s10434-025-18556-3↗
- Paper Impact of CYP2A6 Genotype on Survival Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Receiving Perioperativ… DOI 10.1097/sla.0000000000007152↗
- Paper Comprehensive sequencing of circulating tumour DNA in resectable pancreatic cancer. DOI 10.1093/bjs/znae059↗
- Yukiyasu Okamura · 3 shared papers, 2024–2026 · strength 0.67
- Paper Comparison of Familial and Sporadic Pancreatic Cancer: Clinicopathological and Genomic Features. DOI 10.1245/s10434-025-18556-3↗
- Paper Impact of CYP2A6 Genotype on Survival Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Receiving Perioperativ… DOI 10.1097/sla.0000000000007152↗
- Paper Comprehensive sequencing of circulating tumour DNA in resectable pancreatic cancer. DOI 10.1093/bjs/znae059↗
- Yuya Miura · 2 shared papers, 2026 · strength 0.48
- Ken D Yamaguchi · 2 shared papers, 2024–2026 · strength 0.43
- Mihoko Yamada · 2 shared papers, 2023–2024 · strength 0.34
- Taisuke Imamura · 2 shared papers, 2023–2024 · strength 0.34
- Yoshimi Kiyozumi · 2 shared papers, 2018–2024 · strength 0.26
- Hiroyuki Matsubayashi Md · 2 shared papers, 2018–2024 · strength 0.26
- Yoshiyasu Kato · 1 shared paper, 2026 · strength 0.24
- Takumi Kitahama · 1 shared paper, 2026 · strength 0.24
- Ken Yamaguchi · 2 shared papers, 2018–2023 · strength 0.24
- Akiko Todaka · 1 shared paper, 2024 · strength 0.18
- Sunao Uemura · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.